AUPH PR on settlement of patent disputes with the Indian generic company, Sun is very brief. See entire substantive portion of press...

AUPH PR on settlement of patent disputes with the Indian generic company, Sun is very brief. See entire substantive portion of press release below*. Nothing more filed with SEC.

AUPH PR on settlement of patent disputes with the Indian generic company, Sun is very brief. See entire substantive portion of press release below*. Nothing more filed with SEC. High level of settlement is the following**: Sun gets out of patent infringement litigation and gets covenant not to sue from AUPH for AUPH's '375 and '871 Patents covering Sun's Cequa product for DED Sun agrees to drop USPTO challenge (IPR) against AUPH's '036 Patent '036 Patent relates to using eGFR

(Posted 9:45am CST) $XBI $83.06 | -1.35% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:45am CST) $XBI $83.06 | -1.35% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...